Results 241 to 250 of about 1,906,948 (373)

Beyond the Lung. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Sinonasal Disease in Children With Cystic Fibrosis

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Elexacaftor/tezacaftor/ivacaftor (ETI) is a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) therapy that improves pulmonary function and chronic rhinosinusitis (CRS) in cystic fibrosis (CF) adults with at least one copy of the F508del CFTR mutation.
Margaux Petitjean   +16 more
wiley   +1 more source

Cardiometabolic Disease Risk Factors and Lifestyle Behaviors Among Adolescents: A Latent Class Analysis. [PDF]

open access: yesHealthcare (Basel)
de Faria FR   +6 more
europepmc   +1 more source

Progress in research on osteoporosis secondary to SARS‐CoV‐2 infection

open access: yesAnimal Models and Experimental Medicine, EarlyView.
This review explores the potential mechanisms, complications, risk factors, and future research directions related to osteoporosis secondary to SARS‐CoV‐2 infection. Key mechanisms include an imbalance between osteoclast and osteoblast activity driven by direct viral effects on bone, inflammation, hypoxia, dysregulation of noncoding RNAs, and metabolic
Jinlong Wang   +5 more
wiley   +1 more source

A mixed methods exploration of the experiences of physical activity providers in supporting children and adolescents with type 1 diabetes in the UK. [PDF]

open access: yesEur J Pediatr
Ngamy T   +9 more
europepmc   +1 more source

The use of valve prostheses in congenital heart diseases in children and adolescents

open access: bronze, 1968
Kazumi Taguchi   +5 more
openalex   +1 more source

A harsher reality for adolescents with depression on social media. [PDF]

open access: yesSci Rep
Janssen LHC   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy